Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 17, 2017, Pages 4376-4381

  Leppänen, Veli Matti ^a   Saharinen, Pipsa ^a,b   Alitalo, Kari ^a,b  

^a WIHURI RESEARCH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Angiopoietin; Crystallography; Dimerization; Homotypic interactions; Tyrosine kinase

Indexed keywords

ANGIOPOIETIN RECEPTOR; TIE 1 RECEPTOR;

ARTICLE; CONTROLLED STUDY; DIMERIZATION; ENDOTHELIUM CELL; FIBRONECTIN TYPE III DOMAIN; HELA CELL LINE; HUMAN; HUMAN CELL; INSECT CELL; LYMPH VESSEL; MUTAGENESIS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIZE EXCLUSION CHROMATOGRAPHY; STRUCTURAL HOMOLOGY; X RAY CRYSTALLOGRAPHY;

EID: 85018812730     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1616166114     Document Type: Article

References (55)

1. Chung AS, Ferrara N (2011) Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 27:563-584.
2. Koch S, Claesson-Welsh L (2012) Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med 2:a006502.
3. Augustin HG, Koh GY, Thurston G, Alitalo K (2009) Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10: 165-177.
4. Saharinen P, Jeltsch M, Santoyo MM, Leppänen VM, Alitalo K (2015) The TIE receptor family. Receptor Tyrosine Kinases: Family and Subfamilies, eds Wheeler DE, Yarden Y (Springer International Publishing, Cham, Switzerland), 861:743-775.
5. Saharinen P, Eklund L, Pulkki K, Bono P, Alitalo K (2011) VEGF and angiopoietin signaling in tumor angiogenesis and metastasis. Trends Mol Med 17:347-362.
6. Suri C, et al. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
7. Thurston G, et al. (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6:460-463.
8. Jeansson M, et al. (2011) Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 121:2278-2289.
9. Maisonpierre PC, et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60.
10. Saharinen P, et al. (2008) Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 10:527-537.
11. Yuan HT, Khankin EV, Karumanchi SA, Parikh SM (2009) Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium. Mol Cell Biol 29:2011-2022.
12. D'Amico G, et al. (2014) Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy. J Clin Invest 124:824-834.
13. Korhonen EA, et al. (2016) Tie1 controls angiopoietin function in vascular remodeling and inflammation. J Clin Invest 126:3495-3510.
14. Partanen J, Mäkelä TP, Alitalo R, Lehväslaiho H, Alitalo K (1990) Putative tyrosine kinases expressed in K-562 human leukemia cells. Proc Natl Acad Sci USA 87: 8913-8917.
15. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J (1995) The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14:5884-5891.
16. D'Amico G, et al. (2010) Loss of endothelial Tie1 receptor impairs lymphatic vessel development-brief report. Arterioscler Thromb Vasc Biol 30:207-209.
17. Woo KV, et al. (2011) Tie1 attenuation reduces murine atherosclerosis in a dosedependent and shear stress-specific manner. J Clin Invest 121:1624-1635.
18. Fukuhara S, et al. (2008) Differential function of Tie2 at cell-cell contacts and cellsubstratum contacts regulated by angiopoietin-1. Nat Cell Biol 10:513-526.
19. Cascone I, Napione L, Maniero F, Serini G, Bussolino F (2005) Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J Cell Biol 170:993-1004.
20. Dalton AC, Shlamkovitch T, Papo N, Barton WA (2016) Constitutive association of Tie1 and Tie2 with endothelial integrins is functionally modulated by angiopoietin-1 and fibronectin. PLoS One 11:e0163732.
21. Saharinen P, et al. (2005) Multiple angiopoietin recombinant proteins activate the Tie1 receptor tyrosine kinase and promote its interaction with Tie2. J Cell Biol 169:239-243.
22. Yuan HT, et al. (2007) Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival. FASEB J 21:3171-3183.
23. Savant S, et al. (2015) The orphan receptor Tie1 controls angiogenesis and vascular remodeling by differentially regulating Tie2 in tip and stalk cells. Cell Reports 12:1761-1773.
24. Marron MB, et al. (2007) Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. J Biol Chem 282:30509-30517.
25. Seegar TC, et al. (2010) Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands. Mol Cell 37:643-655.
26. Kim M, et al. (2016) Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation. J Clin Invest 126:3511-3525.
27. Lemmon MA, Schlessinger J (2010) Cell signaling by receptor tyrosine kinases. Cell 141:1117-1134.
28. Procopio WN, Pelavin PI, Lee WM, Yeilding NM (1999) Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity. J Biol Chem 274:30196-30201.
29. Davis S, et al. (2003) Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol 10:38-44.
30. Barton WA, et al. (2006) Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex. Nat Struct Mol Biol 13:524-532.
31. Bogdanovic E, Coombs N, Dumont DJ (2009) Oligomerized Tie2 localizes to clathrincoated pits in response to angiopoietin-1. Histochem Cell Biol 132:225-237.
32. Partanen J, et al. (1992) A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 12: 1698-1707.
33. Yu X, et al. (2013) Structural basis for angiopoietin-1-mediated signaling initiation. Proc Natl Acad Sci USA 110:7205-7210.
34. Cho CH, et al. (2004) COMP-Ang1: A designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci USA 101:5547-5552.
35. Kim KT, et al. (2005) Oligomerization and multimerization are critical for angiopoietin- 1 to bind and phosphorylate Tie2. J Biol Chem 280:20126-20131.
36. Fiedler U, et al. (2003) Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J Biol Chem 278:1721-1727.
37. Macdonald PR, et al. (2006) Structure of the extracellular domain of Tie receptor tyrosine kinases and localization of the angiopoietin-binding epitope. J Biol Chem 281:28408-28414.
38. Souma T, et al. (2016) Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity. J Clin Invest 126:2575-2587.
39. Yuzawa S, et al. (2007) Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor. Cell 130:323-334.
40. Yang Y, Xie P, Opatowsky Y, Schlessinger J (2010) Direct contacts between extracellular membrane-proximal domains are required for VEGF receptor activation and cell signaling. Proc Natl Acad Sci USA 107:1906-1911.
41. Moore JO, Lemmon MA, Ferguson KM (2017) Dimerization of Tie2 mediated by its membrane-proximal FNIII domains. Proc Natl Acad Sci USA 114:4382-4387.
42. Maitra S, Nowic JS (2000) β-Sheet interactions between proteins. The Amide Linkage: Structural Significance in Chemistry, Biochemistry, and Materials Science, eds Greenberg A, Breneman S, Liebman JF (Wiley, New York), pp 495-518.
43. Han S, et al. (2016) Amelioration of sepsis by TIE2 activation-induced vascular protection. Sci Transl Med 8:335ra55.
44. Maruyama IN (2015) Activation of transmembrane cell-surface receptors via a common mechanism? The "rotation model". Bio Essays 37:959-967.
45. Xu K, et al. (2013) Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5. Proc Natl Acad Sci USA 110:14634-14639.
46. Oh N, et al. (2015) A designed angiopoietin-1 variant, dimeric CMP-Ang1 activates Tie2 and stimulates angiogenesis and vascular stabilization in N-glycan dependent manner. Sci Rep 5:15291.
47. Pietilä R, et al. (2012) Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses. J Cell Sci 125:2212-2223.
48. Leppänen VM, et al. (2013) Structural and mechanistic insights into VEGF receptor 3 ligand binding and activation. Proc Natl Acad Sci USA 110:12960-12965.
49. Arkhipov A, et al. (2013) Architecture and membrane interactions of the EGF receptor. Cell 152:557-569.
50. Tvorogov D, et al. (2010) Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization. Cancer Cell 18:630-640.
51. Reshetnyak AV, et al. (2013) Structural basis for KIT receptor tyrosine kinase inhibition by antibodies targeting the D4 membrane-proximal region. Proc Natl Acad Sci USA 110:17832-17837.
52. Kabsch W (2010) Xds. Acta Crystallogr D Biol Crystallogr 66:125-132.
53. Vonrhein C, Blanc E, Roversi P, Bricogne G (2007) Automated structure solution with auto SHARP. Methods Mol Biol 364:215-230.
54. Adams PD, et al. (2010) PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213-221.
55. Petoukhov MV, Svergun DI (2007) Analysis of X-ray and neutron scattering from biomacromolecular solutions. Curr Opin Struct Biol 17:562-571.